Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline UpdateSharon H. Giordano, Nancy E. Davidson, Maria Alice Franzoi et al.|Journal of Clinical Oncology|2022Cited by 181
Management of Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: ASCO Guideline UpdateNaren Ramakrishna, Sharon H. Giordano, Carey K. Anders et al.|Journal of Clinical Oncology|2022Cited by 96
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended prioritiesMichelle M. Kim, Mansoor M. Ahmed, Minesh P. Mehta et al.|The Lancet Oncology|2023Cited by 39
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastasesAnna-Maria Lazaratos, Matthew Dankner, Marcel P. H. van den Broek et al.|The Breast|2023Cited by 25
Examination and prognostic implications of the unique microenvironment of breast cancer brain metastasesMaria J. Sambade, Carey K. Anders, Grace Prince et al.|Breast Cancer Research and Treatment|2019Cited by 23